These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35166515)

  • 1. Maturity-Onset Diabetes of the Young: What You Need to Know.
    Am Fam Physician; 2022 Feb; 105(2):Online. PubMed ID: 35166515
    [No Abstract]   [Full Text] [Related]  

  • 2. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes.
    McDonald TJ; Colclough K; Brown R; Shields B; Shepherd M; Bingley P; Williams A; Hattersley AT; Ellard S
    Diabet Med; 2011 Sep; 28(9):1028-33. PubMed ID: 21395678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current developments in the area of maturity onset diabetes of the young (MODY)].
    Tack CJ
    Ned Tijdschr Geneeskd; 1995 Oct; 139(42):2127-9. PubMed ID: 7477576
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes quiz. How much do you know about prediabetes?
    Butcher M
    Diabetes Self Manag; 2011; 28(5):50, 52. PubMed ID: 22184852
    [No Abstract]   [Full Text] [Related]  

  • 5. Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?
    Majidi S; Fouts A; Pyle L; Chambers C; Armstrong T; Wang Z; Batish SD; Klingensmith G; Steck AK
    Diabetes Technol Ther; 2018 Feb; 20(2):106-112. PubMed ID: 29355436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity-onset diabetes of the young? The case of autoimmunity-associated destruction of pancreatic β-cells in a family of HNF1A-MODY subjects.
    Urbanová J; Rypáčková B; Kučera P; Anděl M; Heneberg P
    Int Arch Allergy Immunol; 2013; 161(3):279-84. PubMed ID: 23548576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unique clinical spectrum of maturity onset diabetes of the young type 3.
    Lebenthal Y; Fisch Shvalb N; Gozlan Y; Tenenbaum A; Tenenbaum-Rakover Y; Vaillant E; Froguel P; Vaxillaire M; Gat-Yablonski G
    Diabetes Res Clin Pract; 2018 Jan; 135():18-22. PubMed ID: 29107759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment.
    Leslie RD; Palmer J; Schloot NC; Lernmark A
    Diabetologia; 2016 Jan; 59(1):13-20. PubMed ID: 26498592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of basal C peptide and its relationship with pancreatic autoantibodies in young adults with type 2 diabetes mellitus.
    Vlad A; Serban V; Sima A; Timar R; Roşu M
    Rom J Intern Med; 2004; 42(2):333-41. PubMed ID: 15529624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maturity onset diabetes of the young (MODY) - screening, diagnostic and therapy].
    Kaser S; Resl M
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S204-7. PubMed ID: 27052244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic approach to the obese maturity-onset diabetic patient.
    Lipson LG; Lipson M
    Arch Intern Med; 1984 Jan; 144(1):135-8. PubMed ID: 6362593
    [No Abstract]   [Full Text] [Related]  

  • 12. [An incidental diagnosis of diabetes mellitus maturity onset diabetes of the young 2].
    Cerezo AM; Alramadan M; López S; Hernández MD; Cortés AB
    Endocrinol Nutr; 2010; 57(6):283-4. PubMed ID: 20494633
    [No Abstract]   [Full Text] [Related]  

  • 13. Towards a systematic nationwide screening strategy for MODY.
    Shields B; Colclough K
    Diabetologia; 2017 Apr; 60(4):609-612. PubMed ID: 28132100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients.
    Shields BM; Shepherd M; Hudson M; McDonald TJ; Colclough K; Peters J; Knight B; Hyde C; Ellard S; Pearson ER; Hattersley AT;
    Diabetes Care; 2017 Aug; 40(8):1017-1025. PubMed ID: 28701371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study.
    Carlsson A; Shepherd M; Ellard S; Weedon M; Lernmark Å; Forsander G; Colclough K; Brahimi Q; Valtonen-Andre C; Ivarsson SA; Elding Larsson H; Samuelsson U; Örtqvist E; Groop L; Ludvigsson J; Marcus C; Hattersley AT
    Diabetes Care; 2020 Jan; 43(1):82-89. PubMed ID: 31704690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes in Asian Indian youth.
    Mohan V; Jaydip R; Deepa R
    Pediatr Diabetes; 2007 Dec; 8 Suppl 9():28-34. PubMed ID: 17991130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis in diabetes: does it matter?
    Thethy I; Robertson L; Swaminathan K
    J R Coll Physicians Edinb; 2011 Jun; 41(2):119-21. PubMed ID: 21677915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coexistence of type 1 diabetes, MODY2 and metabolic syndrome in a young girl.
    Calcaterra V; Martinetti M; Salina A; Aloi C; Larizza D
    Acta Diabetol; 2012 Oct; 49(5):401-4. PubMed ID: 21688019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of maturity onset diabetes of the young (MODY).
    Odawara M; Yamashita K
    Lancet; 1995 May; 345(8960):1313. PubMed ID: 7746085
    [No Abstract]   [Full Text] [Related]  

  • 20. "MODY2" (maturity onset diabetes of the young type 2).
    Heidenreich WF
    J Insur Med; 2014; 44(3):196-200. PubMed ID: 25622392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.